502931-34-2 Usage
Uses
Used in Pharmaceutical Industry:
Isopropyl 4-aminopiperidine-1-carboxylate is used as a pharmaceutical intermediate for the synthesis of medications targeting the central nervous system. It is instrumental in the production of drugs that address various neurological conditions and disorders, leveraging its structural properties to improve the efficacy and bioavailability of these medications.
Used in Research and Development:
In the realm of pharmaceutical research and development, Isopropyl 4-aminopiperidine-1-carboxylate serves as a key component in the creation of novel pharmaceutical compounds. Its unique molecular structure allows for the modification and enhancement of drug properties, leading to the development of new medications with improved efficacy and safety profiles.
Overall, Isopropyl 4-aminopiperidine-1-carboxylate is an indispensable component in the advancement of pharmaceutical products, playing a crucial role in both the synthesis of existing medications and the innovation of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 502931-34-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,2,9,3 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 502931-34:
(8*5)+(7*0)+(6*2)+(5*9)+(4*3)+(3*1)+(2*3)+(1*4)=122
122 % 10 = 2
So 502931-34-2 is a valid CAS Registry Number.
502931-34-2Relevant academic research and scientific papers
NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO
-
, (2011/01/12)
New compounds are disclosed which have utility in the treatment of a variety of metabolic related conditions in a patient. The compounds of this invention have the structure (I): wherein X1, X2, X3, X4, Y1
PYRAZINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS
-
, (2009/10/21)
The application relates to compounds of Formula (Ia), and pharmaceutically acceptable salts, solvates, hydrates, geometrical isomers, tautomers, optical isomers and N-oxides thereof. The application also relates to pharmaceutical compositions comprising t
